Nurix Therapeutics Inc. (NASDAQ: NRIX) Announce Preliminary Findings Showing BTK inhibitor...
Nurix Therapeutics Inc. (NASDAQ: NRIX) has announced preliminary data showing clinically significant Bruton's tyrosine kinase inhibitor degradation in patients with refractory or relapsed B...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Why Just Kitchen Holdings Corp (TSXV: JK) (OTCQB:JKHCF) Has The Potential...
5 years ago, who would have thought something as boring as takeout food could translate into massive shareholder profits? Well, it is....
MAKE IT MODERN
LATEST REVIEWS
VistaGen Therapeutics Inc (NASDAQ: VTGN) Reports Q1 2023 Financial Results And...
VistaGen Therapeutics Inc (NASDAQ: VTGN) has reported financial results for its fiscal Q1 2023 for the quarter ending June 230, 2022, and offered a...
MAKE IT MODERN
PERFORMANCE TRAINING
Can-Fite (NYSEAMERICAN:CANF) Submits Investigational New Drug for a Phase II Study of Piclidenoson in...
Can-Fite (NYSEAMERICAN:CANF) has been using its capabilities to develop an innovative pipeline of patented compounds aimed at treating autoimmune-inflammatory and liver diseases. However, with...
Tonix Pharmaceuticals (NASDAQ:TNXP) Enrols First Participant In PRECISION Study Evaluating Immune Response In Healthy...
Tonix Pharmaceuticals Holdings Inc. (NASDAQ:TNXP) has enrolled its first participant in the observational PRECISION study, TNX-002. The study examines immune response to coronavirus in...
Capricor Therapeutics Inc (NASDAQ: CAPR) Receives Positive Reviews From The Lancet
Capricor Therapeutics Inc (NASDAQ: CAPR) announced that its HOPE-2 Phase II trial had received positive results from The Lancet. The latter has published results...
Charlotte’s Web Holdings Inc (OTCMKTS:CWBHF) Gets Back on the Map with Change at the...
Charlotte's Web Holdings Inc (OTCMKTS:CWBHF) is a leader in the CBD space based on market penetration over recent years.
Tellurian Inc (TELL) Advances Driftwood LNG Project Amid Financial Flexibility Moves, Aims for Strategic...
Tellurian Inc. (TELL), closed its last session at $0.8650, matching its opening price for the day. Amidst active trading, today, bids soared...
MAKE IT MODERN
